A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

November 26, 2024

Primary Completion Date

April 30, 2028

Study Completion Date

April 30, 2028

Conditions
Non-Small Cell Lung CancerLung CancerNSCLCNSCLC (Non-small Cell Lung Carcinoma)EGFR Activating MutationEGFR Mutation-Related Tumors
Interventions
DRUG

BG-60366

Administered orally

Trial Locations (42)

1023

RECRUITING

Harbour Cancer and Wellness, Auckland

10300

RECRUITING

Ramathibodi Hospital Mahidol University, Dusit

20900

NOT_YET_RECRUITING

Fondazione Irccs San Gerardo Dei Tintori Sc Oncologia, Monza

28041

RECRUITING

Hospital Universitario de Octubre, Madrid

28222

RECRUITING

H Puerta de Hierro Majadahonda, Majadahonda

28644

RECRUITING

Chungbuk National University Hospital, SeowonGu CheongjuSi

40002

RECRUITING

Srinagarind Hospital (Khon Kaen University), Muang

40138

NOT_YET_RECRUITING

Irccs Azienda Ospedaliero Universitaria Bologna, Bologna

90110

RECRUITING

Songklanagarind Hospital (Prince of Songkhla University), Hat Yai

93586

RECRUITING

Sarawak General Hospital, Kuching

100142

RECRUITING

Beijing Cancer Hospital, Beijing

300060

RECRUITING

Tianjin Medical University Cancer Institute and Hospital, Tianjin

310018

RECRUITING

Sir Run Run Shaw Hospital, Zhejiang University School of Medicineqiantang Branch, Hangzhou

330006

RECRUITING

The Second Affiliated Hospital of Nanchang University, Nanchang

510120

RECRUITING

Guangdong Provincial Peoples Hospital Huifu Branch, Guangzhou

530201

RECRUITING

The Tumor Hospital Affiliated to Guangxi Medical Universitywuxiang Branch, Nanning

80202-1702

RECRUITING

University of Colorado, Denver

02215-5418

RECRUITING

Dana Farber Cancer Institute, Boston

63110-1032

RECRUITING

Washington University School of Medicine Siteman Cancer Center, St Louis

10065-6800

RECRUITING

Memorial Sloan Kettering Cancer Center Mskcc, New York

43210-1132

NOT_YET_RECRUITING

Ohio State University, Columbus

77030-4009

RECRUITING

The University of Texas Md Anderson Cancer Center, Houston

NSW 2148

RECRUITING

Blacktown Cancer and Haematology Centre, Blacktown

NSW 2170

RECRUITING

Liverpool Hospital, Liverpool

QLD 4102

RECRUITING

Princess Alexandra Hospital, Woolloongabba

SA 5000

RECRUITING

Cancer Research South Australia, Adelaide

VIC 3084

RECRUITING

Austin Health, Heidelberg

VIC 3000

RECRUITING

Peter Maccallum Cancer Centre, Melbourne

14.784-400

NOT_YET_RECRUITING

Fundacao Pio Xii Hospital de Amor de Barretos, Barretos

59062-000

NOT_YET_RECRUITING

Liga Norte Riograndene Contra O Cancer, Natal

90610-000

NOT_YET_RECRUITING

Hospital Sao Lucas Da Pucrs, Porto Alegre

41253-190

NOT_YET_RECRUITING

Hospital Sao Rafael (Rede Dor), Salvador

15090-000

NOT_YET_RECRUITING

Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto, São José do Rio Preto

01246-000

NOT_YET_RECRUITING

Icesp Instituto Do Cancer Do Estado de Sao Paulo Octavio Frias de Oliveira, São Paulo

05652-900

NOT_YET_RECRUITING

Hospital Israelita Albert Einstein, São Paulo

29043-260

NOT_YET_RECRUITING

Hospital Santa Rita de Cassia Afecc, Vitória

030032

RECRUITING

Shanxi Bethune Hospital, Taiyuan

00168

RECRUITING

Fondazione Policlinico Universitario Agostino Gemelli, Roma

06351

RECRUITING

Samsung Medical Center, GangnamGu

03722

RECRUITING

Severance Hospital Yonsei University Health System, SeodaemunGu

03080

RECRUITING

Seoul National University Hospital, Seoul

08035

RECRUITING

Hospital Universitario Vall Dhebron, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

BeiGene

INDUSTRY